Company / Total Assets
Protagonist Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$668.2M
FY2025
5-year range
$247.9M / $744.7M
FY2021-FY2025
Trend
-10.3%
vs FY2024
Sector context
#114 of 214
Health Care
What the data says
At $668M, Protagonist Therapeutics, Inc.'s total assets ranks #114 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $94M in FY2016 to $745M in FY2024.
Based on SEC 10-K filings.
$668M in FY2025 with a 5-year CAGR of +15.5%.
Improved from $358M to $668M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +39.2%
- 5-Year CAGR
- +15.5%
- 10-Year CAGR
- -
Sector benchmark
#114 of 214 in Health CareTop 53% of 214This company $668.2M Sector average $7.5B
▼
-91.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.5%, indicating consistent growth.
- In FY2025, total assets decreased 10.3% year-over-year.
- Ranks #114 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $668.2M | -10.3% |
| FY2024 | $744.7M | +108.1% |
| FY2023 | $358.0M | +44.4% |
| FY2022 | $247.9M | -28.7% |
| FY2021 | $347.7M | +7.2% |
| FY2020 | $324.5M | +109.4% |
| FY2019 | $154.9M | +11.1% |
| FY2018 | $139.5M | -14.8% |
| FY2017 | $163.7M | +74.2% |
| FY2016 | $94.0M | +533.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026